Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Blood (2019) 134 (Supplement_1): 4497.

https://doi.org/10.1182/blood-2019-127961

Published: 2019

Journal Articles

Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis

Heather Morris, PharmD, BCPS, Meredith T. Moorman, PharmD, BCOP, CPP, Melissa C. Mackey, PharmD, BCPS, BCOP, Harry P. Erba, MD PhD, Thomas W. LeBlanc, MDMA,MHS, David A. Rizzieri, MD, Ian Barak, MS, Zhiguo Li, PhD, Tanya Zapolskaya, PharmD, BCPS, BCOP

Blood (2019) 134 (Supplement_1): 5105.

https://doi.org/10.1182/blood-2019-132197

Published: 2019

Journal Articles

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Melanie T Cushion, PhD MS, Alan Ashbaugh, Voon Ong, PhD

Blood (2019) 134 (Supplement_1): 3266.

https://doi.org/10.1182/blood-2019-127392

Published: 2019

Journal Articles

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Jeremy Chang, MD, Golnaz Vahdani, MD, George Yaghmour, MD, Ashley Weissman, PharmD, Kum-Ja Lee, PharmD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 4630.

https://doi.org/10.1182/blood-2018-99-111404

Published: 2018

Journal Articles

Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients

Elizabeth A Lakota, PharmD, MS, Shawn Flanagan, PhD, Taylor Sandison, MD, MPH, Janice W Brown, MD, Christopher M Rubino, Pharm.D.

Blood (2018) 132 (Supplement 1): 2071.

https://doi.org/10.1182/blood-2018-99-110300

Published: 2018

Journal Articles

Efficacy of CD101, a Novel Echinocandin, in Mouse Models of Aspergillosis and Azole-Resistant Disseminated Candidiasis

Voon Ong, PhD, Ken Bartizal, PhD, Lynn Miesel, PhD

Blood (2016) 128 (22): 3400.

https://doi.org/10.1182/blood.V128.22.3400.3400

Published: 2016

Journal Articles

Efficacy of CD101, a Novel Echinocandin, in Prevention of Pneumocystis Pneumonia (PCP): Thwarting the Biphasic Life Cycle of Pneumocystis

Melanie Cushion, Alan Ashbaugh, Keeley Lynch, Michael J. Linke, Ken Bartizal, PhD

Blood (2016) 128 (22): 3396.

https://doi.org/10.1182/blood.V128.22.3396.3396

Published: 2016

Journal Articles

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Taylor Sandison, MD MPH, Voon Ong, PhD, Dirk Thye, MD

Blood (2016) 128 (22): 2197.

https://doi.org/10.1182/blood.V128.22.2197.2197

Published: 2016

Journal Articles

Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

Michael J. Burke, MD, Patrick Brown, MD, Richard Sposto, PhD, Lia Gore, MD, Alan S. Wayne, MD

Blood (2016) 128 (22): 2781.

https://doi.org/10.1182/blood.V128.22.2781.2781

Published: 2016

Journal Articles

Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia

Anna B. Halpern, Gary H. Lyman, Thomas J. Walsh, Dimitrios P. Kontoyiannis, Roland B. Walter

Blood (2015) 126 (26): 2790–2797.

https://doi.org/10.1182/blood-2015-07-627323

Published: 2015

Includes: Supplemental data

Journal Articles

Epidemiology of Fungemia in Hematological Malignancies: Preliminary Report of Seifem-2015 Survey

Blood (2015) 126 (23): 4887.

https://doi.org/10.1182/blood.V126.23.4887.4887

Published: 2015

Journal Articles

Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

Michael J. Burke, MD, Patrick Brown, MD, Lia Gore, MD, Richard Sposto, PhD, Deepa Bhojwani, Bill H Chang, MD PhD, Steven G. Dubois, MD, Paul S Gaynon, MD, Julia Glade-Bender, MD, Kenneth Matthew Heym, MD, Maria Luisa Sulis, MD, Jessica A. Pollard, MD, Anupam Verma, MD, Van Huynh, MD

Blood (2014) 124 (21): 3650.

https://doi.org/10.1182/blood.V124.21.3650.3650

Published: 2014

Journal Articles

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Lucrecia Yáñez, MD, Noemí Fernández, MD, Arancha Bermudez, MD, Germán Pérez, MD, Andres Insunza, MD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 1154.

https://doi.org/10.1182/blood.V124.21.1154.1154

Published: 2014

Journal Articles

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

Jean El-Cheikh, MD PhD, Geoffroy Venton, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Catherine Faucher, Angela Granata, Claire Oudin, Reda Bouabdallah, MD, Norbert Vey, MD, Segolene Duran, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4505.

https://doi.org/10.1182/blood.V120.21.4505.4505

Published: 2012

Journal Articles

Efficacy and Safety of Micafungin for the Prophylaxis of Invasive Fungal Disease During Neutropenia in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2012) 120 (21): 1932.

https://doi.org/10.1182/blood.V120.21.1932.1932

Published: 2012

Journal Articles

Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States

Marko Kavcic, MD, Brian T. Fisher, DO, MSCE, Jeffrey S. Gerber, MD, PhD, Kateri H. Leckerman, MS, Yimei Li, PhD, Yuan-Shung Huang, MS, Alix E. Seif, MD, MPH, Kari Torp, Rochelle Bagatell, MD, Richard Aplenc, MD, PhD

Blood (2012) 120 (21): 4278.

https://doi.org/10.1182/blood.V120.21.4278.4278

Published: 2012

Journal Articles

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Marko Kavcic, MD, Brian T. Fisher, DO, MSCE, Yimei Li, PhD, Alix E. Seif, MD, MPH, Kari Torp, Yuan-Shung Huang, MS, Grace E. Lee, MD, Sarah K Tasian, MD, Ami V. Desai, MD, Marijana Vujkovic, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD, PhD

Blood (2012) 120 (21): 4283.

https://doi.org/10.1182/blood.V120.21.4283.4283

Published: 2012

Journal Articles

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

Giridharan Ramsingh, MD, Andrew Sprau, M.S, Peter Westervelt, MD, PhD, Ali McBride, PharmD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD, Geoffrey L. Uy, MD, Amanda Cashen, MD, John F. DiPersio, MD, PhD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3609.

https://doi.org/10.1182/blood.V118.21.3609.3609

Published: 2011

Journal Articles

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

P. Dayand Borge, Jr., MD, Narda Theobald, MA, Rosamma DeCastro, NP, Harry L. Malech, MD, Susan Leitman, MD, Elizabeth M. Kang, MD

Blood (2010) 116 (21): 1329.

https://doi.org/10.1182/blood.V116.21.1329.1329

Published: 2010

Journal Articles

Improved Survival using Dual Monoclonal Antibody Therapy with Aggressive Anti-Microbial Prophylaxis In Steroid-Refractory Acute Graft-Versus-Host Disease

Melissa Sanacore, PharmD, Karen Manion, RN, Pauline Smith, RN, Xu Zhang, PhD, H. Kent Holland, MD, Lawrence Morris, MD, Scott R. Solomon, MD, Asad Bashey, MD, PhD

Blood (2010) 116 (21): 1262.

https://doi.org/10.1182/blood.V116.21.1262.1262

Published: 2010

NARROW

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Pharmacokinetic-Pharmacodynamic Analyses to Provide Rezafungin Prophylaxis Dose Selection for Prevention of Invasive Fungal Infections for Bone Marrow Transplant Patients

Efficacy of CD101, a Novel Echinocandin, in Mouse Models of Aspergillosis and Azole-Resistant Disseminated Candidiasis

Efficacy of CD101, a Novel Echinocandin, in Prevention of Pneumocystis Pneumonia (PCP): Thwarting the Biphasic Life Cycle of Pneumocystis

Pharmacokinetics, Safety, and Target Attainment of Single and Multiple Doses of CD101 IV

Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia

Epidemiology of Fungemia in Hematological Malignancies: Preliminary Report of Seifem-2015 Survey

Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Efficacy and Safety of Micafungin for Prophylaxis of Invasive Fungal Infections in Patients Undergoing Haplo-Identical Hematopoietic Stem Cell Transplant

Efficacy and Safety of Micafungin for the Prophylaxis of Invasive Fungal Disease During Neutropenia in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Variability in Antifungal Use for Pediatric Acute Myeloid Leukemia At Children's Hospitals Across the United States

Mortality and Resource Utilization in Children with De Novo Acute Myeloid Leukemia Treated with Chemotherapy and Gemtuzumab Ozogamicin in the United States

Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML,

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

Improved Survival using Dual Monoclonal Antibody Therapy with Aggressive Anti-Microbial Prophylaxis In Steroid-Refractory Acute Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only